None
Quote | Oragenics Inc. (NYSE:OGEN)
Last: | $2.33 |
---|---|
Change Percent: | 2.44% |
Open: | $1.6 |
Close: | $2.33 |
High: | $2.4 |
Low: | $1.6 |
Volume: | 521,437 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
News | Oragenics Inc. (NYSE:OGEN)
2024-05-17 14:15:35 ET More on Mid-day movers & stocks. Broadwind, Inc. (BWEN) Q1 2024 Earnings Call Transcript Broadwind, Inc. 2024 Q1 - Results - Earnings Call Presentation Broadwind, Inc. (BWEN) Q4 2023 Earnings Call Transcript Oragenics climbs 9% amid...
SARASOTA, Fla., May 17, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneering pharmaceutical company specializing in intranasal treatments for neurological disorders, today announced that the company will host a webinar panel on Neurotrauma Medicine Monday, May 20, 2024, at...
Message Board Posts | Oragenics Inc. (NYSE:OGEN)
Subject | By | Source | When |
---|---|---|---|
Maybe not. :) | retired early | investorshub | 03/01/2023 6:46:26 PM |
Don't madder they will short it down to nothing | Nathan123456 | investorshub | 12/22/2022 10:32:36 PM |
Surfs up. ::) | retired early | investorshub | 12/22/2022 2:35:47 PM |
Chart setup perfectly here -> time is koming | BEIJING BILL | investorshub | 08/17/2022 4:51:49 PM |
Hey whatever it takes to see it rise | retired early | investorshub | 05/27/2022 5:06:22 PM |
News, Short Squeeze, Breakout and More Instantly...
SARASOTA, Fla., May 17, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneering pharmaceutical company specializing in intranasal treatments for neurological disorders, today announced that the company will host a webinar panel on Neurotrauma Medicine Monday, May 20, 2024, at...
SARASOTA, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneering pharmaceutical company specializing in intranasal treatments for neurological disorders, today announced an update on the company and its drug development program. Oragenics is designing an upcomi...
A look at the top 10 most actives in the United States Novavax Inc. (NVAX) rose 98.7% to $8.88 on volume of 168,692,127 shares AEye Inc. (LIDR) rose 115.0% to $2.58 on volume of 156,236,079 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) fell 17.3% to $0.7609 on volume of 123,678,040 s...